Short answer
Incyte (INCY) filed its Q2 2025 10-Q quarterly report on Jul 29, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $1.2B (up 16.5% year over year) with net income of $405M.
Q2 2025 key financials · XBRL
- Revenue
- $1.2B
- +16.5% YoY · +15.4% QoQ
- Net income
- $405M
- +191.1% YoY · +156.0% QoQ
- Operating margin
- 43.6%
- EPS (diluted)
- $2.04
- +202.5% YoY · +155.0% QoQ
Source: XBRL data from the Incyte (INCY) Q2 2025 10-Q on SEC EDGAR. USD.
Incyte Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,215.5M Q2 2025, up 16.4% YoY from $1,043.8M Q2 2024; 6-month revenue $2,268.4M up 17.9% YoY
- Net income $405.0M Q2 2025 vs loss $444.6M Q2 2024; operating expenses R&D $494.9M Q2 2025 vs $1,138.4M Q2 2024
- Best segment JAKAFI revenue $763.8M Q2 2025 up 8.2% YoY; worst performing PEMAZYRE revenue $22.2M up 9.3% YoY but smallest absolute growth
- Cash $2.4B at June 30, 2025; operating cash flow $310.8M for 6 months 2025 vs -$356.8M for 6 months 2024 due to contract dispute and prior acquisition
- Management expects future sales allowances to fluctuate; evaluating tax legislation impacts; believes cash and credit facility sufficient for foreseeable capital needs
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Incyte quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.